CoChat

Intensive glucose control and macrovascular outcomes in type 2 diabetes

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Aims/hypothesis Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, compared with less-intensive, glucose control on the risk of major cardiovascular events amongst patients with type 2 diabetes.Methods A prospectively planned group-level meta-analysis in which characteristics of trials to be included, outcomes of interest, analyses and subgroup definitions were all pre-specified.Results A total of 27,049 participants and 2,370 major vascular events contributed to the meta-analyses. Allocation to more-intensive, compared with less-intensive, glucose control reduced the risk of major cardiovascular events by 9% (HR 0.91, 95% CI 0.84-0.99), primarily because of a 15% reduced risk of myocardial infarction (HR 0.85, 95% CI 0.76-0.94). Mortality was not decreased, with non-significant HRs of 1.04 for all-cause mortality (95% CI 0.90-1.20) and 1.10 for cardiovascular death (95% CI 0.84-1.42). Intensively treated participants had significantly more major hypoglycaemic events (HR 2.48, 95% CI 1.91-3.21). Exploratory subgroup analyses suggested the possibility of a differential effect for major cardiovascular events in participants with and without macrovascular disease (HR 1.00, 95% CI 0.89-1.13, vs HR 0.84, 95% CI 0.74-0.94, respectively; interaction p = 0.04).Conclusions/interpretation Targeting more-intensive glucose lowering modestly reduced major macrovascular events and increased major hypoglycaemia over 4.4 years in persons with type 2 diabetes. The analyses suggest that glucose-lowering regimens should be tailored to the individual.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00125-009-1470-0

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 22 references

Cited by

See all 1,189

Metadata

Authors
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., Neal, B. C., Ninomiya, T., Patel, A. A., Paul, S. K., Travert, F., & Woodward, M.
Affiliations
  • The University of Sydney (AU)
  • United States Department of Veterans Affairs (US)
  • Veterans Health Administration (US)
  • Wake Forest University Health Sciences (US)
  • Population Health Research Institute (CA)
  • University of Oxford (GB)
  • Assistance Publique – Hôpitaux de Paris (FR)
Corresponding author
Turnbull, F. M.
Venue
Diabetologia
Published
2009-08-05
Volume
52
Issue
11
Pages
2288-2298
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1983269691
Cited by
1,189
References
22
Citations by year
2026: 18 · 2025: 26 · 2024: 43 · 2023: 61 · 2022: 57 · 2021: 72 · 2020: 73 · 2019: 86 · 2018: 90 · 2017: 80 · 2016: 82 · 2015: 75 · 2014: 83 · 2013: 89 · 2012: 85
FWCI
61.19
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
  • Servier
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, tight glycemic control, macroangiopathy, cardiovascular events, myocardial infarction, hypoglycemia, all-cause mortality, cardiovascular mortality, glucose-lowering therapy, personalized treatment
MeSH terms
Blood Glucose, Blood Pressure, Cholesterol, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Fasting, Follow-Up Studies, Glycated Hemoglobin, Homeostasis, Humans, Patient Compliance, Treatment Outcome, Patient Selection, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensive glucose control and macrovascular outcomes in type 2 diabetes. https://app.cochat.ai/papers/10.1007/s00125-009-1470-0
The paper
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., Neal, B. C., Ninomiya, T., Patel, A. A., Paul, S. K., Travert, F., & Woodward, M. (2009). Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-009-1470-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.